nodes	percent_of_prediction	percent_of_DWPC	metapath
Dabrafenib—ABCB1—ulcerative colitis	0.225	1	CbGaD
Dabrafenib—SLC22A8—Mercaptopurine—ulcerative colitis	0.062	0.126	CbGbCtD
Dabrafenib—SLCO1B1—Sulfasalazine—ulcerative colitis	0.0547	0.111	CbGbCtD
Dabrafenib—ABCG2—Sulfasalazine—ulcerative colitis	0.0435	0.0884	CbGbCtD
Dabrafenib—ABCG2—Hydrocortisone—ulcerative colitis	0.0349	0.0709	CbGbCtD
Dabrafenib—CYP2C8—Nicotine—ulcerative colitis	0.0298	0.0605	CbGbCtD
Dabrafenib—CYP3A4—Budesonide—ulcerative colitis	0.0277	0.0564	CbGbCtD
Dabrafenib—CYP2C8—Cholecalciferol—ulcerative colitis	0.0267	0.0543	CbGbCtD
Dabrafenib—ABCG2—Dexamethasone—ulcerative colitis	0.0217	0.0441	CbGbCtD
Dabrafenib—ABCB1—Methylprednisolone—ulcerative colitis	0.0207	0.0421	CbGbCtD
Dabrafenib—CYP2C8—Hydrocortisone—ulcerative colitis	0.0186	0.0378	CbGbCtD
Dabrafenib—ABCB1—Betamethasone—ulcerative colitis	0.0134	0.0273	CbGbCtD
Dabrafenib—ABCB1—Prednisolone—ulcerative colitis	0.0133	0.027	CbGbCtD
Dabrafenib—ABCB1—Hydrocortisone—ulcerative colitis	0.0126	0.0256	CbGbCtD
Dabrafenib—ABCB1—Prednisone—ulcerative colitis	0.0125	0.0255	CbGbCtD
Dabrafenib—CYP3A4—Methylprednisolone—ulcerative colitis	0.0124	0.0252	CbGbCtD
Dabrafenib—CYP3A4—Nicotine—ulcerative colitis	0.0121	0.0246	CbGbCtD
Dabrafenib—CYP2C8—Dexamethasone—ulcerative colitis	0.0116	0.0235	CbGbCtD
Dabrafenib—CYP3A4—Cholecalciferol—ulcerative colitis	0.0108	0.022	CbGbCtD
Dabrafenib—CYP3A4—Triamcinolone—ulcerative colitis	0.00939	0.0191	CbGbCtD
Dabrafenib—CYP3A4—Betamethasone—ulcerative colitis	0.00806	0.0164	CbGbCtD
Dabrafenib—CYP3A4—Prednisolone—ulcerative colitis	0.00795	0.0162	CbGbCtD
Dabrafenib—ABCB1—Dexamethasone—ulcerative colitis	0.00782	0.0159	CbGbCtD
Dabrafenib—CYP3A4—Hydrocortisone—ulcerative colitis	0.00754	0.0153	CbGbCtD
Dabrafenib—CYP3A4—Prednisone—ulcerative colitis	0.00751	0.0153	CbGbCtD
Dabrafenib—CYP3A4—Dexamethasone—ulcerative colitis	0.00469	0.00953	CbGbCtD
Dabrafenib—Eye disorder—Hydrocortisone—ulcerative colitis	0.000184	0.00119	CcSEcCtD
Dabrafenib—Hypotension—Mesalazine—ulcerative colitis	0.000184	0.00119	CcSEcCtD
Dabrafenib—Connective tissue disorder—Methylprednisolone—ulcerative colitis	0.000181	0.00118	CcSEcCtD
Dabrafenib—Arrhythmia—Prednisolone—ulcerative colitis	0.00018	0.00117	CcSEcCtD
Dabrafenib—Pancreatitis—Prednisone—ulcerative colitis	0.000179	0.00116	CcSEcCtD
Dabrafenib—Musculoskeletal discomfort—Mesalazine—ulcerative colitis	0.000179	0.00116	CcSEcCtD
Dabrafenib—Hypersensitivity—Budesonide—ulcerative colitis	0.000178	0.00116	CcSEcCtD
Dabrafenib—Insomnia—Mesalazine—ulcerative colitis	0.000178	0.00115	CcSEcCtD
Dabrafenib—Immune system disorder—Hydrocortisone—ulcerative colitis	0.000178	0.00115	CcSEcCtD
Dabrafenib—Gastrointestinal pain—Azathioprine—ulcerative colitis	0.000176	0.00115	CcSEcCtD
Dabrafenib—Arrhythmia—Hydrocortisone—ulcerative colitis	0.000176	0.00114	CcSEcCtD
Dabrafenib—Erythema—Prednisolone—ulcerative colitis	0.000175	0.00114	CcSEcCtD
Dabrafenib—Asthenia—Budesonide—ulcerative colitis	0.000173	0.00113	CcSEcCtD
Dabrafenib—Eye disorder—Methylprednisolone—ulcerative colitis	0.000173	0.00112	CcSEcCtD
Dabrafenib—Mental disorder—Hydrocortisone—ulcerative colitis	0.000172	0.00112	CcSEcCtD
Dabrafenib—Erythema—Hydrocortisone—ulcerative colitis	0.000171	0.00111	CcSEcCtD
Dabrafenib—Malnutrition—Hydrocortisone—ulcerative colitis	0.000171	0.00111	CcSEcCtD
Dabrafenib—Neutropenia—Prednisone—ulcerative colitis	0.000171	0.00111	CcSEcCtD
Dabrafenib—Pruritus—Budesonide—ulcerative colitis	0.000171	0.00111	CcSEcCtD
Dabrafenib—Decreased appetite—Mesalazine—ulcerative colitis	0.000171	0.00111	CcSEcCtD
Dabrafenib—Body temperature increased—Azathioprine—ulcerative colitis	0.00017	0.00111	CcSEcCtD
Dabrafenib—Abdominal pain—Azathioprine—ulcerative colitis	0.00017	0.00111	CcSEcCtD
Dabrafenib—Gastrointestinal disorder—Mesalazine—ulcerative colitis	0.00017	0.0011	CcSEcCtD
Dabrafenib—Fatigue—Mesalazine—ulcerative colitis	0.000169	0.0011	CcSEcCtD
Dabrafenib—Haemoglobin—Dexamethasone—ulcerative colitis	0.000169	0.0011	CcSEcCtD
Dabrafenib—Haemoglobin—Betamethasone—ulcerative colitis	0.000169	0.0011	CcSEcCtD
Dabrafenib—Constipation—Mesalazine—ulcerative colitis	0.000168	0.00109	CcSEcCtD
Dabrafenib—Haemorrhage—Betamethasone—ulcerative colitis	0.000168	0.00109	CcSEcCtD
Dabrafenib—Haemorrhage—Dexamethasone—ulcerative colitis	0.000168	0.00109	CcSEcCtD
Dabrafenib—Angiopathy—Methylprednisolone—ulcerative colitis	0.000168	0.00109	CcSEcCtD
Dabrafenib—Immune system disorder—Methylprednisolone—ulcerative colitis	0.000167	0.00108	CcSEcCtD
Dabrafenib—Mediastinal disorder—Methylprednisolone—ulcerative colitis	0.000166	0.00108	CcSEcCtD
Dabrafenib—Arrhythmia—Triamcinolone—ulcerative colitis	0.000165	0.00107	CcSEcCtD
Dabrafenib—Diarrhoea—Budesonide—ulcerative colitis	0.000165	0.00107	CcSEcCtD
Dabrafenib—Vision blurred—Prednisolone—ulcerative colitis	0.000165	0.00107	CcSEcCtD
Dabrafenib—Arrhythmia—Methylprednisolone—ulcerative colitis	0.000165	0.00107	CcSEcCtD
Dabrafenib—Hyperglycaemia—Prednisone—ulcerative colitis	0.000165	0.00107	CcSEcCtD
Dabrafenib—Mental disorder—Methylprednisolone—ulcerative colitis	0.000162	0.00105	CcSEcCtD
Dabrafenib—Erythema—Triamcinolone—ulcerative colitis	0.000161	0.00105	CcSEcCtD
Dabrafenib—Malnutrition—Methylprednisolone—ulcerative colitis	0.000161	0.00104	CcSEcCtD
Dabrafenib—Erythema—Methylprednisolone—ulcerative colitis	0.000161	0.00104	CcSEcCtD
Dabrafenib—Gastrointestinal pain—Mesalazine—ulcerative colitis	0.000161	0.00104	CcSEcCtD
Dabrafenib—Dizziness—Budesonide—ulcerative colitis	0.00016	0.00104	CcSEcCtD
Dabrafenib—Hypersensitivity—Azathioprine—ulcerative colitis	0.000159	0.00103	CcSEcCtD
Dabrafenib—Eye disorder—Betamethasone—ulcerative colitis	0.000157	0.00102	CcSEcCtD
Dabrafenib—Eye disorder—Dexamethasone—ulcerative colitis	0.000157	0.00102	CcSEcCtD
Dabrafenib—Back pain—Triamcinolone—ulcerative colitis	0.000156	0.00101	CcSEcCtD
Dabrafenib—Body temperature increased—Mesalazine—ulcerative colitis	0.000155	0.00101	CcSEcCtD
Dabrafenib—Abdominal pain—Mesalazine—ulcerative colitis	0.000155	0.00101	CcSEcCtD
Dabrafenib—Vomiting—Budesonide—ulcerative colitis	0.000154	0.000998	CcSEcCtD
Dabrafenib—Angiopathy—Betamethasone—ulcerative colitis	0.000152	0.00099	CcSEcCtD
Dabrafenib—Angiopathy—Dexamethasone—ulcerative colitis	0.000152	0.00099	CcSEcCtD
Dabrafenib—Rash—Budesonide—ulcerative colitis	0.000152	0.00099	CcSEcCtD
Dabrafenib—Dermatitis—Budesonide—ulcerative colitis	0.000152	0.000989	CcSEcCtD
Dabrafenib—Headache—Budesonide—ulcerative colitis	0.000151	0.000983	CcSEcCtD
Dabrafenib—Hypertension—Prednisolone—ulcerative colitis	0.000151	0.000983	CcSEcCtD
Dabrafenib—Arrhythmia—Dexamethasone—ulcerative colitis	0.00015	0.000975	CcSEcCtD
Dabrafenib—Arrhythmia—Betamethasone—ulcerative colitis	0.00015	0.000975	CcSEcCtD
Dabrafenib—Alopecia—Betamethasone—ulcerative colitis	0.000148	0.000965	CcSEcCtD
Dabrafenib—Alopecia—Dexamethasone—ulcerative colitis	0.000148	0.000965	CcSEcCtD
Dabrafenib—Hypertension—Hydrocortisone—ulcerative colitis	0.000148	0.00096	CcSEcCtD
Dabrafenib—Diarrhoea—Azathioprine—ulcerative colitis	0.000148	0.000959	CcSEcCtD
Dabrafenib—Haemoglobin—Prednisone—ulcerative colitis	0.000147	0.000955	CcSEcCtD
Dabrafenib—Haemorrhage—Prednisone—ulcerative colitis	0.000146	0.000951	CcSEcCtD
Dabrafenib—Erythema—Betamethasone—ulcerative colitis	0.000146	0.00095	CcSEcCtD
Dabrafenib—Erythema—Dexamethasone—ulcerative colitis	0.000146	0.00095	CcSEcCtD
Dabrafenib—Myalgia—Hydrocortisone—ulcerative colitis	0.000146	0.000947	CcSEcCtD
Dabrafenib—Hypersensitivity—Mesalazine—ulcerative colitis	0.000145	0.00094	CcSEcCtD
Dabrafenib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—ulcerative colitis	0.000145	0.00094	CcSEcCtD
Dabrafenib—Connective tissue disorder—Prednisone—ulcerative colitis	0.000144	0.000934	CcSEcCtD
Dabrafenib—Nausea—Budesonide—ulcerative colitis	0.000143	0.000932	CcSEcCtD
Dabrafenib—Oedema—Prednisolone—ulcerative colitis	0.000143	0.000929	CcSEcCtD
Dabrafenib—Dizziness—Azathioprine—ulcerative colitis	0.000143	0.000927	CcSEcCtD
Dabrafenib—Asthenia—Mesalazine—ulcerative colitis	0.000141	0.000916	CcSEcCtD
Dabrafenib—Cough—Triamcinolone—ulcerative colitis	0.000141	0.000914	CcSEcCtD
Dabrafenib—Oedema—Hydrocortisone—ulcerative colitis	0.00014	0.000908	CcSEcCtD
Dabrafenib—Hypertension—Triamcinolone—ulcerative colitis	0.000139	0.000904	CcSEcCtD
Dabrafenib—Pruritus—Mesalazine—ulcerative colitis	0.000139	0.000903	CcSEcCtD
Dabrafenib—Hypertension—Methylprednisolone—ulcerative colitis	0.000139	0.000902	CcSEcCtD
Dabrafenib—Infection—Hydrocortisone—ulcerative colitis	0.000139	0.000902	CcSEcCtD
Dabrafenib—Hyperhidrosis—Prednisolone—ulcerative colitis	0.000138	0.000898	CcSEcCtD
Dabrafenib—Myalgia—Triamcinolone—ulcerative colitis	0.000137	0.000892	CcSEcCtD
Dabrafenib—Vomiting—Azathioprine—ulcerative colitis	0.000137	0.000891	CcSEcCtD
Dabrafenib—Nervous system disorder—Hydrocortisone—ulcerative colitis	0.000137	0.00089	CcSEcCtD
Dabrafenib—Myalgia—Methylprednisolone—ulcerative colitis	0.000137	0.00089	CcSEcCtD
Dabrafenib—Arthralgia—Methylprednisolone—ulcerative colitis	0.000137	0.00089	CcSEcCtD
Dabrafenib—Eye disorder—Prednisone—ulcerative colitis	0.000137	0.000888	CcSEcCtD
Dabrafenib—Rash—Azathioprine—ulcerative colitis	0.000136	0.000884	CcSEcCtD
Dabrafenib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	0.000136	0.000883	CcSEcCtD
Dabrafenib—Dermatitis—Azathioprine—ulcerative colitis	0.000136	0.000883	CcSEcCtD
Dabrafenib—Skin disorder—Hydrocortisone—ulcerative colitis	0.000136	0.000882	CcSEcCtD
Dabrafenib—Headache—Azathioprine—ulcerative colitis	0.000135	0.000878	CcSEcCtD
Dabrafenib—Hyperhidrosis—Hydrocortisone—ulcerative colitis	0.000135	0.000877	CcSEcCtD
Dabrafenib—Diarrhoea—Mesalazine—ulcerative colitis	0.000134	0.000873	CcSEcCtD
Dabrafenib—Dry mouth—Triamcinolone—ulcerative colitis	0.000134	0.000872	CcSEcCtD
Dabrafenib—Angiopathy—Prednisone—ulcerative colitis	0.000133	0.000862	CcSEcCtD
Dabrafenib—Immune system disorder—Prednisone—ulcerative colitis	0.000132	0.000859	CcSEcCtD
Dabrafenib—Oedema—Triamcinolone—ulcerative colitis	0.000132	0.000855	CcSEcCtD
Dabrafenib—Arrhythmia—Prednisone—ulcerative colitis	0.000131	0.000849	CcSEcCtD
Dabrafenib—Infection—Triamcinolone—ulcerative colitis	0.000131	0.000849	CcSEcCtD
Dabrafenib—Hypotension—Hydrocortisone—ulcerative colitis	0.000131	0.000848	CcSEcCtD
Dabrafenib—Infection—Methylprednisolone—ulcerative colitis	0.00013	0.000847	CcSEcCtD
Dabrafenib—Dizziness—Mesalazine—ulcerative colitis	0.00013	0.000844	CcSEcCtD
Dabrafenib—Insomnia—Prednisolone—ulcerative colitis	0.000129	0.000841	CcSEcCtD
Dabrafenib—Alopecia—Prednisone—ulcerative colitis	0.000129	0.00084	CcSEcCtD
Dabrafenib—Nervous system disorder—Methylprednisolone—ulcerative colitis	0.000129	0.000836	CcSEcCtD
Dabrafenib—Mental disorder—Prednisone—ulcerative colitis	0.000128	0.000833	CcSEcCtD
Dabrafenib—Nausea—Azathioprine—ulcerative colitis	0.000128	0.000832	CcSEcCtD
Dabrafenib—Skin disorder—Methylprednisolone—ulcerative colitis	0.000127	0.000828	CcSEcCtD
Dabrafenib—Erythema—Prednisone—ulcerative colitis	0.000127	0.000827	CcSEcCtD
Dabrafenib—Malnutrition—Prednisone—ulcerative colitis	0.000127	0.000827	CcSEcCtD
Dabrafenib—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	0.000127	0.000827	CcSEcCtD
Dabrafenib—Hyperhidrosis—Triamcinolone—ulcerative colitis	0.000127	0.000826	CcSEcCtD
Dabrafenib—Hyperhidrosis—Methylprednisolone—ulcerative colitis	0.000127	0.000824	CcSEcCtD
Dabrafenib—Insomnia—Hydrocortisone—ulcerative colitis	0.000126	0.000821	CcSEcCtD
Dabrafenib—Hypertension—Dexamethasone—ulcerative colitis	0.000126	0.00082	CcSEcCtD
Dabrafenib—Hypertension—Betamethasone—ulcerative colitis	0.000126	0.00082	CcSEcCtD
Dabrafenib—Vomiting—Mesalazine—ulcerative colitis	0.000125	0.000812	CcSEcCtD
Dabrafenib—Myalgia—Dexamethasone—ulcerative colitis	0.000124	0.000809	CcSEcCtD
Dabrafenib—Myalgia—Betamethasone—ulcerative colitis	0.000124	0.000809	CcSEcCtD
Dabrafenib—Rash—Mesalazine—ulcerative colitis	0.000124	0.000805	CcSEcCtD
Dabrafenib—Dermatitis—Mesalazine—ulcerative colitis	0.000124	0.000804	CcSEcCtD
Dabrafenib—Headache—Mesalazine—ulcerative colitis	0.000123	0.0008	CcSEcCtD
Dabrafenib—Hypotension—Methylprednisolone—ulcerative colitis	0.000123	0.000797	CcSEcCtD
Dabrafenib—Decreased appetite—Hydrocortisone—ulcerative colitis	0.000121	0.000789	CcSEcCtD
Dabrafenib—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	0.000121	0.000784	CcSEcCtD
Dabrafenib—Fatigue—Hydrocortisone—ulcerative colitis	0.00012	0.000783	CcSEcCtD
Dabrafenib—Vision blurred—Prednisone—ulcerative colitis	0.00012	0.00078	CcSEcCtD
Dabrafenib—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	0.00012	0.000779	CcSEcCtD
Dabrafenib—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	0.00012	0.000777	CcSEcCtD
Dabrafenib—Oedema—Dexamethasone—ulcerative colitis	0.000119	0.000775	CcSEcCtD
Dabrafenib—Oedema—Betamethasone—ulcerative colitis	0.000119	0.000775	CcSEcCtD
Dabrafenib—Insomnia—Triamcinolone—ulcerative colitis	0.000119	0.000773	CcSEcCtD
Dabrafenib—Insomnia—Methylprednisolone—ulcerative colitis	0.000119	0.000771	CcSEcCtD
Dabrafenib—Infection—Betamethasone—ulcerative colitis	0.000119	0.00077	CcSEcCtD
Dabrafenib—Infection—Dexamethasone—ulcerative colitis	0.000119	0.00077	CcSEcCtD
Dabrafenib—Anaemia—Prednisone—ulcerative colitis	0.000118	0.000765	CcSEcCtD
Dabrafenib—Nervous system disorder—Dexamethasone—ulcerative colitis	0.000117	0.00076	CcSEcCtD
Dabrafenib—Nervous system disorder—Betamethasone—ulcerative colitis	0.000117	0.00076	CcSEcCtD
Dabrafenib—Thrombocytopenia—Betamethasone—ulcerative colitis	0.000117	0.000759	CcSEcCtD
Dabrafenib—Thrombocytopenia—Dexamethasone—ulcerative colitis	0.000117	0.000759	CcSEcCtD
Dabrafenib—Nausea—Mesalazine—ulcerative colitis	0.000117	0.000758	CcSEcCtD
Dabrafenib—Hyperhidrosis—Betamethasone—ulcerative colitis	0.000115	0.00075	CcSEcCtD
Dabrafenib—Hyperhidrosis—Dexamethasone—ulcerative colitis	0.000115	0.00075	CcSEcCtD
Dabrafenib—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	0.000114	0.000742	CcSEcCtD
Dabrafenib—Fatigue—Triamcinolone—ulcerative colitis	0.000113	0.000737	CcSEcCtD
Dabrafenib—Fatigue—Methylprednisolone—ulcerative colitis	0.000113	0.000735	CcSEcCtD
Dabrafenib—Hypotension—Dexamethasone—ulcerative colitis	0.000111	0.000725	CcSEcCtD
Dabrafenib—Hypotension—Betamethasone—ulcerative colitis	0.000111	0.000725	CcSEcCtD
Dabrafenib—Body temperature increased—Hydrocortisone—ulcerative colitis	0.00011	0.000718	CcSEcCtD
Dabrafenib—Abdominal pain—Hydrocortisone—ulcerative colitis	0.00011	0.000718	CcSEcCtD
Dabrafenib—Hypertension—Prednisone—ulcerative colitis	0.00011	0.000714	CcSEcCtD
Dabrafenib—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	0.000109	0.000707	CcSEcCtD
Dabrafenib—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	0.000109	0.000707	CcSEcCtD
Dabrafenib—Myalgia—Prednisone—ulcerative colitis	0.000108	0.000704	CcSEcCtD
Dabrafenib—Arthralgia—Prednisone—ulcerative colitis	0.000108	0.000704	CcSEcCtD
Dabrafenib—Insomnia—Betamethasone—ulcerative colitis	0.000108	0.000701	CcSEcCtD
Dabrafenib—Insomnia—Dexamethasone—ulcerative colitis	0.000108	0.000701	CcSEcCtD
Dabrafenib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	0.000108	0.0007	CcSEcCtD
Dabrafenib—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	0.000107	0.000697	CcSEcCtD
Dabrafenib—Hypersensitivity—Prednisolone—ulcerative colitis	0.000105	0.000685	CcSEcCtD
Dabrafenib—Body temperature increased—Triamcinolone—ulcerative colitis	0.000104	0.000676	CcSEcCtD
Dabrafenib—Oedema—Prednisone—ulcerative colitis	0.000104	0.000675	CcSEcCtD
Dabrafenib—Abdominal pain—Methylprednisolone—ulcerative colitis	0.000104	0.000674	CcSEcCtD
Dabrafenib—Decreased appetite—Dexamethasone—ulcerative colitis	0.000104	0.000674	CcSEcCtD
Dabrafenib—Decreased appetite—Betamethasone—ulcerative colitis	0.000104	0.000674	CcSEcCtD
Dabrafenib—Infection—Prednisone—ulcerative colitis	0.000103	0.000671	CcSEcCtD
Dabrafenib—Gastrointestinal disorder—Betamethasone—ulcerative colitis	0.000103	0.00067	CcSEcCtD
Dabrafenib—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	0.000103	0.00067	CcSEcCtD
Dabrafenib—Hypersensitivity—Hydrocortisone—ulcerative colitis	0.000103	0.000669	CcSEcCtD
Dabrafenib—Fatigue—Dexamethasone—ulcerative colitis	0.000103	0.000669	CcSEcCtD
Dabrafenib—Fatigue—Betamethasone—ulcerative colitis	0.000103	0.000669	CcSEcCtD
Dabrafenib—Nervous system disorder—Prednisone—ulcerative colitis	0.000102	0.000662	CcSEcCtD
Dabrafenib—Skin disorder—Prednisone—ulcerative colitis	0.000101	0.000656	CcSEcCtD
Dabrafenib—Hyperhidrosis—Prednisone—ulcerative colitis	0.0001	0.000653	CcSEcCtD
Dabrafenib—Asthenia—Hydrocortisone—ulcerative colitis	0.0001	0.000651	CcSEcCtD
Dabrafenib—Pruritus—Hydrocortisone—ulcerative colitis	9.88e-05	0.000642	CcSEcCtD
Dabrafenib—Gastrointestinal pain—Betamethasone—ulcerative colitis	9.76e-05	0.000634	CcSEcCtD
Dabrafenib—Gastrointestinal pain—Dexamethasone—ulcerative colitis	9.76e-05	0.000634	CcSEcCtD
Dabrafenib—Hypersensitivity—Triamcinolone—ulcerative colitis	9.69e-05	0.00063	CcSEcCtD
Dabrafenib—Hypersensitivity—Methylprednisolone—ulcerative colitis	9.67e-05	0.000628	CcSEcCtD
Dabrafenib—Diarrhoea—Hydrocortisone—ulcerative colitis	9.56e-05	0.000621	CcSEcCtD
Dabrafenib—Musculoskeletal discomfort—Prednisone—ulcerative colitis	9.47e-05	0.000615	CcSEcCtD
Dabrafenib—Dizziness—Prednisolone—ulcerative colitis	9.46e-05	0.000615	CcSEcCtD
Dabrafenib—Asthenia—Triamcinolone—ulcerative colitis	9.43e-05	0.000613	CcSEcCtD
Dabrafenib—Abdominal pain—Betamethasone—ulcerative colitis	9.43e-05	0.000613	CcSEcCtD
Dabrafenib—Abdominal pain—Dexamethasone—ulcerative colitis	9.43e-05	0.000613	CcSEcCtD
Dabrafenib—Body temperature increased—Dexamethasone—ulcerative colitis	9.43e-05	0.000613	CcSEcCtD
Dabrafenib—Body temperature increased—Betamethasone—ulcerative colitis	9.43e-05	0.000613	CcSEcCtD
Dabrafenib—Asthenia—Methylprednisolone—ulcerative colitis	9.41e-05	0.000612	CcSEcCtD
Dabrafenib—Insomnia—Prednisone—ulcerative colitis	9.4e-05	0.000611	CcSEcCtD
Dabrafenib—Pruritus—Triamcinolone—ulcerative colitis	9.3e-05	0.000605	CcSEcCtD
Dabrafenib—Pruritus—Methylprednisolone—ulcerative colitis	9.28e-05	0.000603	CcSEcCtD
Dabrafenib—Dizziness—Hydrocortisone—ulcerative colitis	9.24e-05	0.0006	CcSEcCtD
Dabrafenib—Decreased appetite—Prednisone—ulcerative colitis	9.03e-05	0.000587	CcSEcCtD
Dabrafenib—Rash—Prednisolone—ulcerative colitis	9.02e-05	0.000586	CcSEcCtD
Dabrafenib—Dermatitis—Prednisolone—ulcerative colitis	9.01e-05	0.000585	CcSEcCtD
Dabrafenib—Diarrhoea—Methylprednisolone—ulcerative colitis	8.98e-05	0.000583	CcSEcCtD
Dabrafenib—Fatigue—Prednisone—ulcerative colitis	8.96e-05	0.000582	CcSEcCtD
Dabrafenib—Headache—Prednisolone—ulcerative colitis	8.96e-05	0.000582	CcSEcCtD
Dabrafenib—Constipation—Prednisone—ulcerative colitis	8.89e-05	0.000578	CcSEcCtD
Dabrafenib—Vomiting—Hydrocortisone—ulcerative colitis	8.88e-05	0.000577	CcSEcCtD
Dabrafenib—Rash—Hydrocortisone—ulcerative colitis	8.81e-05	0.000572	CcSEcCtD
Dabrafenib—Dermatitis—Hydrocortisone—ulcerative colitis	8.8e-05	0.000572	CcSEcCtD
Dabrafenib—Headache—Hydrocortisone—ulcerative colitis	8.75e-05	0.000569	CcSEcCtD
Dabrafenib—Dizziness—Triamcinolone—ulcerative colitis	8.7e-05	0.000565	CcSEcCtD
Dabrafenib—Dizziness—Methylprednisolone—ulcerative colitis	8.68e-05	0.000564	CcSEcCtD
Dabrafenib—Asthenia—Dexamethasone—ulcerative colitis	8.56e-05	0.000556	CcSEcCtD
Dabrafenib—Asthenia—Betamethasone—ulcerative colitis	8.56e-05	0.000556	CcSEcCtD
Dabrafenib—Gastrointestinal pain—Prednisone—ulcerative colitis	8.5e-05	0.000552	CcSEcCtD
Dabrafenib—Nausea—Prednisolone—ulcerative colitis	8.49e-05	0.000552	CcSEcCtD
Dabrafenib—Pruritus—Dexamethasone—ulcerative colitis	8.44e-05	0.000549	CcSEcCtD
Dabrafenib—Pruritus—Betamethasone—ulcerative colitis	8.44e-05	0.000549	CcSEcCtD
Dabrafenib—Vomiting—Triamcinolone—ulcerative colitis	8.36e-05	0.000543	CcSEcCtD
Dabrafenib—Vomiting—Methylprednisolone—ulcerative colitis	8.34e-05	0.000542	CcSEcCtD
Dabrafenib—Nausea—Hydrocortisone—ulcerative colitis	8.3e-05	0.000539	CcSEcCtD
Dabrafenib—Rash—Triamcinolone—ulcerative colitis	8.29e-05	0.000539	CcSEcCtD
Dabrafenib—Dermatitis—Triamcinolone—ulcerative colitis	8.28e-05	0.000538	CcSEcCtD
Dabrafenib—Rash—Methylprednisolone—ulcerative colitis	8.27e-05	0.000538	CcSEcCtD
Dabrafenib—Dermatitis—Methylprednisolone—ulcerative colitis	8.27e-05	0.000537	CcSEcCtD
Dabrafenib—Headache—Triamcinolone—ulcerative colitis	8.24e-05	0.000535	CcSEcCtD
Dabrafenib—Headache—Methylprednisolone—ulcerative colitis	8.22e-05	0.000534	CcSEcCtD
Dabrafenib—Abdominal pain—Prednisone—ulcerative colitis	8.21e-05	0.000534	CcSEcCtD
Dabrafenib—Body temperature increased—Prednisone—ulcerative colitis	8.21e-05	0.000534	CcSEcCtD
Dabrafenib—Diarrhoea—Betamethasone—ulcerative colitis	8.16e-05	0.000531	CcSEcCtD
Dabrafenib—Diarrhoea—Dexamethasone—ulcerative colitis	8.16e-05	0.000531	CcSEcCtD
Dabrafenib—Dizziness—Dexamethasone—ulcerative colitis	7.89e-05	0.000513	CcSEcCtD
Dabrafenib—Dizziness—Betamethasone—ulcerative colitis	7.89e-05	0.000513	CcSEcCtD
Dabrafenib—Nausea—Triamcinolone—ulcerative colitis	7.81e-05	0.000508	CcSEcCtD
Dabrafenib—Nausea—Methylprednisolone—ulcerative colitis	7.79e-05	0.000507	CcSEcCtD
Dabrafenib—Hypersensitivity—Prednisone—ulcerative colitis	7.66e-05	0.000498	CcSEcCtD
Dabrafenib—Vomiting—Dexamethasone—ulcerative colitis	7.59e-05	0.000493	CcSEcCtD
Dabrafenib—Vomiting—Betamethasone—ulcerative colitis	7.59e-05	0.000493	CcSEcCtD
Dabrafenib—Rash—Betamethasone—ulcerative colitis	7.52e-05	0.000489	CcSEcCtD
Dabrafenib—Rash—Dexamethasone—ulcerative colitis	7.52e-05	0.000489	CcSEcCtD
Dabrafenib—Dermatitis—Betamethasone—ulcerative colitis	7.52e-05	0.000489	CcSEcCtD
Dabrafenib—Dermatitis—Dexamethasone—ulcerative colitis	7.52e-05	0.000489	CcSEcCtD
Dabrafenib—Headache—Betamethasone—ulcerative colitis	7.47e-05	0.000486	CcSEcCtD
Dabrafenib—Headache—Dexamethasone—ulcerative colitis	7.47e-05	0.000486	CcSEcCtD
Dabrafenib—Asthenia—Prednisone—ulcerative colitis	7.46e-05	0.000485	CcSEcCtD
Dabrafenib—Pruritus—Prednisone—ulcerative colitis	7.35e-05	0.000478	CcSEcCtD
Dabrafenib—Diarrhoea—Prednisone—ulcerative colitis	7.11e-05	0.000462	CcSEcCtD
Dabrafenib—Nausea—Dexamethasone—ulcerative colitis	7.09e-05	0.000461	CcSEcCtD
Dabrafenib—Nausea—Betamethasone—ulcerative colitis	7.09e-05	0.000461	CcSEcCtD
Dabrafenib—Dizziness—Prednisone—ulcerative colitis	6.87e-05	0.000447	CcSEcCtD
Dabrafenib—Vomiting—Prednisone—ulcerative colitis	6.61e-05	0.000429	CcSEcCtD
Dabrafenib—Rash—Prednisone—ulcerative colitis	6.55e-05	0.000426	CcSEcCtD
Dabrafenib—Dermatitis—Prednisone—ulcerative colitis	6.55e-05	0.000425	CcSEcCtD
Dabrafenib—Headache—Prednisone—ulcerative colitis	6.51e-05	0.000423	CcSEcCtD
Dabrafenib—Nausea—Prednisone—ulcerative colitis	6.17e-05	0.000401	CcSEcCtD
Dabrafenib—RAF1—MAPK Signaling Pathway—TNF—ulcerative colitis	3.4e-05	0.000264	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by NGF—RELA—ulcerative colitis	3.39e-05	0.000262	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	3.38e-05	0.000262	CbGpPWpGaD
Dabrafenib—BRAF—NGF signalling via TRKA from the plasma membrane—IL6—ulcerative colitis	3.37e-05	0.000261	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—JAK2—ulcerative colitis	3.36e-05	0.00026	CbGpPWpGaD
Dabrafenib—LIMK1—Developmental Biology—IL6—ulcerative colitis	3.35e-05	0.000259	CbGpPWpGaD
Dabrafenib—RAF1—NGF signalling via TRKA from the plasma membrane—STAT3—ulcerative colitis	3.34e-05	0.000259	CbGpPWpGaD
Dabrafenib—RAF1—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	3.3e-05	0.000256	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—IFNG—ulcerative colitis	3.3e-05	0.000255	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—IRF8—ulcerative colitis	3.29e-05	0.000255	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—CCR6—ulcerative colitis	3.29e-05	0.000255	CbGpPWpGaD
Dabrafenib—RAF1—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	3.28e-05	0.000255	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—CXCR2—ulcerative colitis	3.27e-05	0.000253	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—RELA—ulcerative colitis	3.25e-05	0.000252	CbGpPWpGaD
Dabrafenib—RAF1—Disease—SLC11A1—ulcerative colitis	3.2e-05	0.000248	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—ADCY5—ulcerative colitis	3.2e-05	0.000248	CbGpPWpGaD
Dabrafenib—SLC22A6—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	3.18e-05	0.000247	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—CD4—ulcerative colitis	3.18e-05	0.000247	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—PTGER4—ulcerative colitis	3.17e-05	0.000246	CbGpPWpGaD
Dabrafenib—RAF1—Axon guidance—JAK2—ulcerative colitis	3.16e-05	0.000245	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by SCF-KIT—IL6—ulcerative colitis	3.16e-05	0.000245	CbGpPWpGaD
Dabrafenib—RAF1—Hemostasis—MMP1—ulcerative colitis	3.14e-05	0.000244	CbGpPWpGaD
Dabrafenib—ABCB1—Allograft Rejection—TGFB1—ulcerative colitis	3.14e-05	0.000243	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—FCGR2A—ulcerative colitis	3.14e-05	0.000243	CbGpPWpGaD
Dabrafenib—RAF1—Cytokine Signaling in Immune system—IL1B—ulcerative colitis	3.11e-05	0.000241	CbGpPWpGaD
Dabrafenib—SLCO1B1—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	3.11e-05	0.000241	CbGpPWpGaD
Dabrafenib—RAF1—Cytokine Signaling in Immune system—IL2—ulcerative colitis	3.1e-05	0.00024	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—PTGS1—ulcerative colitis	3.09e-05	0.00024	CbGpPWpGaD
Dabrafenib—RAF1—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	3.08e-05	0.000238	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—CCR6—ulcerative colitis	3.07e-05	0.000238	CbGpPWpGaD
Dabrafenib—RAF1—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	3.07e-05	0.000238	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	3.04e-05	0.000236	CbGpPWpGaD
Dabrafenib—RAF1—Downstream signaling of activated FGFR—IL6—ulcerative colitis	3.02e-05	0.000234	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—PTPN2—ulcerative colitis	3.01e-05	0.000233	CbGpPWpGaD
Dabrafenib—RAF1—MAPK Signaling Pathway—TP53—ulcerative colitis	3e-05	0.000232	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by ERBB4—IL6—ulcerative colitis	2.97e-05	0.00023	CbGpPWpGaD
Dabrafenib—LIMK1—Innate Immune System—IL6—ulcerative colitis	2.96e-05	0.000229	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—IL1B—ulcerative colitis	2.94e-05	0.000228	CbGpPWpGaD
Dabrafenib—ABCB1—Allograft Rejection—TNF—ulcerative colitis	2.93e-05	0.000227	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—IL2—ulcerative colitis	2.93e-05	0.000227	CbGpPWpGaD
Dabrafenib—RAF1—Platelet activation, signaling and aggregation—TGFB1—ulcerative colitis	2.92e-05	0.000227	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—MAML2—ulcerative colitis	2.91e-05	0.000226	CbGpPWpGaD
Dabrafenib—RAF1—Cytokine Signaling in Immune system—NFKB1—ulcerative colitis	2.9e-05	0.000225	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—GHRL—ulcerative colitis	2.9e-05	0.000225	CbGpPWpGaD
Dabrafenib—SLCO1B1—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	2.9e-05	0.000225	CbGpPWpGaD
Dabrafenib—SLCO1B3—Transmembrane transport of small molecules—ALB—ulcerative colitis	2.89e-05	0.000224	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—CXCR1—ulcerative colitis	2.89e-05	0.000224	CbGpPWpGaD
Dabrafenib—RAF1—Disease—MAML2—ulcerative colitis	2.88e-05	0.000223	CbGpPWpGaD
Dabrafenib—ABCG2—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	2.88e-05	0.000223	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—CHP1—ulcerative colitis	2.86e-05	0.000222	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by NGF—NFKB1—ulcerative colitis	2.86e-05	0.000221	CbGpPWpGaD
Dabrafenib—RAF1—Downstream signal transduction—IL6—ulcerative colitis	2.84e-05	0.00022	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by FGFR—IL6—ulcerative colitis	2.82e-05	0.000219	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—CALM3—ulcerative colitis	2.81e-05	0.000218	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by ERBB2—IL6—ulcerative colitis	2.81e-05	0.000218	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—CRP—ulcerative colitis	2.8e-05	0.000217	CbGpPWpGaD
Dabrafenib—RAF1—DAP12 signaling—IL6—ulcerative colitis	2.8e-05	0.000217	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—CALM3—ulcerative colitis	2.78e-05	0.000216	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—NFKB1—ulcerative colitis	2.74e-05	0.000213	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—PTGER4—ulcerative colitis	2.71e-05	0.00021	CbGpPWpGaD
Dabrafenib—RAF1—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	2.7e-05	0.00021	CbGpPWpGaD
Dabrafenib—ABCB1—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	2.7e-05	0.000209	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—PPARG—ulcerative colitis	2.7e-05	0.000209	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—TLR4—ulcerative colitis	2.68e-05	0.000208	CbGpPWpGaD
Dabrafenib—ABCG2—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	2.68e-05	0.000208	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	2.68e-05	0.000208	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	2.66e-05	0.000206	CbGpPWpGaD
Dabrafenib—RAF1—DAP12 interactions—IL6—ulcerative colitis	2.63e-05	0.000204	CbGpPWpGaD
Dabrafenib—RAF1—Fc epsilon receptor (FCERI) signaling—IL6—ulcerative colitis	2.63e-05	0.000204	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by FGFR in disease—IL6—ulcerative colitis	2.63e-05	0.000204	CbGpPWpGaD
Dabrafenib—RAF1—Axon guidance—MMP9—ulcerative colitis	2.61e-05	0.000202	CbGpPWpGaD
Dabrafenib—RAF1—Cytokine Signaling in Immune system—STAT3—ulcerative colitis	2.61e-05	0.000202	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by EGFR—IL6—ulcerative colitis	2.61e-05	0.000202	CbGpPWpGaD
Dabrafenib—BRAF—Signaling by NGF—IL6—ulcerative colitis	2.59e-05	0.000201	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by EGFR in Cancer—IL6—ulcerative colitis	2.58e-05	0.0002	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—HLA-DRB1—ulcerative colitis	2.57e-05	0.0002	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by PDGF—IL6—ulcerative colitis	2.57e-05	0.000199	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—CALM3—ulcerative colitis	2.57e-05	0.000199	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by NGF—STAT3—ulcerative colitis	2.57e-05	0.000199	CbGpPWpGaD
Dabrafenib—SLC22A8—Transmembrane transport of small molecules—ALB—ulcerative colitis	2.56e-05	0.000198	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—CCL20—ulcerative colitis	2.54e-05	0.000197	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—RIPK2—ulcerative colitis	2.53e-05	0.000196	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—CTLA4—ulcerative colitis	2.49e-05	0.000193	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—CHP1—ulcerative colitis	2.49e-05	0.000193	CbGpPWpGaD
Dabrafenib—BRAF—Disease—ADCY5—ulcerative colitis	2.49e-05	0.000193	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—GHRL—ulcerative colitis	2.48e-05	0.000192	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—ICAM1—ulcerative colitis	2.47e-05	0.000191	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—DLD—ulcerative colitis	2.47e-05	0.000191	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—STAT3—ulcerative colitis	2.46e-05	0.000191	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—ADRB2—ulcerative colitis	2.4e-05	0.000186	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—CALM3—ulcerative colitis	2.4e-05	0.000186	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—GNA12—ulcerative colitis	2.39e-05	0.000185	CbGpPWpGaD
Dabrafenib—RAF1—Hemostasis—ALB—ulcerative colitis	2.38e-05	0.000185	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—CD79A—ulcerative colitis	2.38e-05	0.000184	CbGpPWpGaD
Dabrafenib—RAF1—Disease—CALM3—ulcerative colitis	2.37e-05	0.000184	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—RIPK2—ulcerative colitis	2.36e-05	0.000183	CbGpPWpGaD
Dabrafenib—RAF1—NGF signalling via TRKA from the plasma membrane—IL6—ulcerative colitis	2.33e-05	0.000181	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—NOD2—ulcerative colitis	2.29e-05	0.000178	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—CD14—ulcerative colitis	2.28e-05	0.000177	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	2.27e-05	0.000176	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—CXCR2—ulcerative colitis	2.26e-05	0.000175	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—JAK2—ulcerative colitis	2.26e-05	0.000175	CbGpPWpGaD
Dabrafenib—RAF1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	2.25e-05	0.000175	CbGpPWpGaD
Dabrafenib—RAF1—Hemostasis—JAK2—ulcerative colitis	2.21e-05	0.000172	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—VCAM1—ulcerative colitis	2.2e-05	0.000171	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—HLA-DQA1—ulcerative colitis	2.19e-05	0.00017	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—RELA—ulcerative colitis	2.19e-05	0.00017	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—CDH1—ulcerative colitis	2.18e-05	0.000169	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—ABCB1—ulcerative colitis	2.16e-05	0.000168	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—DLD—ulcerative colitis	2.15e-05	0.000167	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—ulcerative colitis	2.14e-05	0.000166	CbGpPWpGaD
Dabrafenib—SLC22A6—Transmembrane transport of small molecules—ALB—ulcerative colitis	2.14e-05	0.000166	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—CCR6—ulcerative colitis	2.13e-05	0.000165	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—PTGS1—ulcerative colitis	2.08e-05	0.000161	CbGpPWpGaD
Dabrafenib—RAF1—Transmembrane transport of small molecules—ALB—ulcerative colitis	2.06e-05	0.00016	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—ADRB2—ulcerative colitis	2.05e-05	0.000159	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	2.04e-05	0.000158	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—ADCY5—ulcerative colitis	2.04e-05	0.000158	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—ADCY5—ulcerative colitis	2.02e-05	0.000157	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—MAML2—ulcerative colitis	2.02e-05	0.000156	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—JAK2—ulcerative colitis	1.99e-05	0.000155	CbGpPWpGaD
Dabrafenib—SLCO1B1—Transmembrane transport of small molecules—ALB—ulcerative colitis	1.94e-05	0.000151	CbGpPWpGaD
Dabrafenib—RAF1—Hemostasis—IL2—ulcerative colitis	1.93e-05	0.00015	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—RELA—ulcerative colitis	1.93e-05	0.00015	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—PTGS1—ulcerative colitis	1.92e-05	0.000149	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—CD4—ulcerative colitis	1.89e-05	0.000147	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—PTGER4—ulcerative colitis	1.87e-05	0.000145	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—CALM3—ulcerative colitis	1.87e-05	0.000145	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—MMP9—ulcerative colitis	1.86e-05	0.000144	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—ADCY5—ulcerative colitis	1.86e-05	0.000144	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	1.86e-05	0.000144	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—RELA—ulcerative colitis	1.85e-05	0.000144	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—NFKB1—ulcerative colitis	1.84e-05	0.000143	CbGpPWpGaD
Dabrafenib—RAF1—Cytokine Signaling in Immune system—IL6—ulcerative colitis	1.82e-05	0.000141	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—CD4—ulcerative colitis	1.81e-05	0.000141	CbGpPWpGaD
Dabrafenib—ABCG2—Transmembrane transport of small molecules—ALB—ulcerative colitis	1.8e-05	0.000139	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by NGF—IL6—ulcerative colitis	1.79e-05	0.000139	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	1.79e-05	0.000139	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—ADCY5—ulcerative colitis	1.74e-05	0.000135	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—CALM3—ulcerative colitis	1.73e-05	0.000134	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—IL6—ulcerative colitis	1.72e-05	0.000133	CbGpPWpGaD
Dabrafenib—RAF1—Disease—ADCY5—ulcerative colitis	1.72e-05	0.000133	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—GHRL—ulcerative colitis	1.71e-05	0.000133	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—CALM3—ulcerative colitis	1.66e-05	0.000129	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—STAT3—ulcerative colitis	1.66e-05	0.000128	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—RIPK2—ulcerative colitis	1.64e-05	0.000127	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—CRP—ulcerative colitis	1.63e-05	0.000126	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—NFKB1—ulcerative colitis	1.63e-05	0.000126	CbGpPWpGaD
Dabrafenib—RAF1—Axon guidance—IL6—ulcerative colitis	1.62e-05	0.000126	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—NFKB1—ulcerative colitis	1.56e-05	0.000121	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—TLR4—ulcerative colitis	1.56e-05	0.000121	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—HLA-DRB1—ulcerative colitis	1.56e-05	0.000121	CbGpPWpGaD
Dabrafenib—BRAF—Disease—JAK2—ulcerative colitis	1.55e-05	0.00012	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	1.55e-05	0.00012	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—TGFB1—ulcerative colitis	1.54e-05	0.000119	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—CHP1—ulcerative colitis	1.54e-05	0.000119	CbGpPWpGaD
Dabrafenib—RAF1—Hemostasis—TGFB1—ulcerative colitis	1.51e-05	0.000117	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—PPARG—ulcerative colitis	1.51e-05	0.000117	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—ICAM1—ulcerative colitis	1.5e-05	0.000116	CbGpPWpGaD
Dabrafenib—BRAF—Disease—CD4—ulcerative colitis	1.47e-05	0.000114	CbGpPWpGaD
Dabrafenib—BRAF—Disease—PTGS2—ulcerative colitis	1.46e-05	0.000113	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—ABCB1—ulcerative colitis	1.45e-05	0.000113	CbGpPWpGaD
Dabrafenib—ABCB1—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	1.45e-05	0.000112	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	1.45e-05	0.000112	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—TNF—ulcerative colitis	1.43e-05	0.000111	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—ADRB2—ulcerative colitis	1.42e-05	0.00011	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—ADCY5—ulcerative colitis	1.36e-05	0.000105	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—ALB—ulcerative colitis	1.35e-05	0.000105	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—ABCB1—ulcerative colitis	1.35e-05	0.000104	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—DLD—ulcerative colitis	1.33e-05	0.000103	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—CDH1—ulcerative colitis	1.32e-05	0.000103	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1.31e-05	0.000101	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	1.28e-05	9.89e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—JAK2—ulcerative colitis	1.27e-05	9.85e-05	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—ADCY5—ulcerative colitis	1.26e-05	9.74e-05	CbGpPWpGaD
Dabrafenib—RAF1—Hemostasis—TP53—ulcerative colitis	1.24e-05	9.62e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—ADCY5—ulcerative colitis	1.2e-05	9.34e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—PTGS1—ulcerative colitis	1.19e-05	9.25e-05	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—PTGS2—ulcerative colitis	1.18e-05	9.19e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	1.17e-05	9.1e-05	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—JAK2—ulcerative colitis	1.16e-05	9e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—CXCL8—ulcerative colitis	1.16e-05	8.99e-05	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—IL6—ulcerative colitis	1.16e-05	8.97e-05	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—IFNG—ulcerative colitis	1.14e-05	8.84e-05	CbGpPWpGaD
Dabrafenib—BRAF—Disease—STAT3—ulcerative colitis	1.14e-05	8.82e-05	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—RELA—ulcerative colitis	1.12e-05	8.72e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—IL2—ulcerative colitis	1.11e-05	8.6e-05	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—CD4—ulcerative colitis	1.1e-05	8.54e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—JAK2—ulcerative colitis	1.09e-05	8.41e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—CALM3—ulcerative colitis	1.07e-05	8.33e-05	CbGpPWpGaD
Dabrafenib—RAF1—Disease—JAK2—ulcerative colitis	1.07e-05	8.31e-05	CbGpPWpGaD
Dabrafenib—BRAF—Disease—TGFB1—ulcerative colitis	1.05e-05	8.17e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—RELA—ulcerative colitis	1.05e-05	8.15e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—PTGS1—ulcerative colitis	1.04e-05	8.06e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	1.03e-05	7.96e-05	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—IL6—ulcerative colitis	1.02e-05	7.93e-05	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—IL1B—ulcerative colitis	1.02e-05	7.88e-05	CbGpPWpGaD
Dabrafenib—RAF1—Disease—CD4—ulcerative colitis	1.02e-05	7.88e-05	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—IL2—ulcerative colitis	1.01e-05	7.85e-05	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—PPARG—ulcerative colitis	1.01e-05	7.85e-05	CbGpPWpGaD
Dabrafenib—RAF1—Disease—PTGS2—ulcerative colitis	1.01e-05	7.82e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—CXCL8—ulcerative colitis	9.9e-06	7.68e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Transmembrane transport of small molecules—ALB—ulcerative colitis	9.72e-06	7.54e-05	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—NFKB1—ulcerative colitis	9.48e-06	7.35e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—IL2—ulcerative colitis	9.47e-06	7.34e-05	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—PPARG—ulcerative colitis	9.37e-06	7.26e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—CALM3—ulcerative colitis	9.36e-06	7.26e-05	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—ALB—ulcerative colitis	9.1e-06	7.05e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—MMP9—ulcerative colitis	8.96e-06	6.95e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—NFKB1—ulcerative colitis	8.86e-06	6.87e-05	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—STAT3—ulcerative colitis	8.52e-06	6.61e-05	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—ALB—ulcerative colitis	8.42e-06	6.53e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—ABCB1—ulcerative colitis	8.36e-06	6.48e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—STAT3—ulcerative colitis	7.96e-06	6.18e-05	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—PTGS2—ulcerative colitis	7.96e-06	6.17e-05	CbGpPWpGaD
Dabrafenib—BRAF—Disease—IL6—ulcerative colitis	7.94e-06	6.16e-05	CbGpPWpGaD
Dabrafenib—RAF1—Disease—STAT3—ulcerative colitis	7.87e-06	6.1e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—ADCY5—ulcerative colitis	7.8e-06	6.04e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—JAK2—ulcerative colitis	7.51e-06	5.82e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—TGFB1—ulcerative colitis	7.38e-06	5.72e-05	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—PTGS2—ulcerative colitis	7.37e-06	5.71e-05	CbGpPWpGaD
Dabrafenib—RAF1—Disease—TGFB1—ulcerative colitis	7.29e-06	5.66e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—RELA—ulcerative colitis	7.27e-06	5.64e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—CXCL8—ulcerative colitis	6.85e-06	5.31e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—ADCY5—ulcerative colitis	6.79e-06	5.27e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—IL2—ulcerative colitis	6.55e-06	5.08e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—IL6—ulcerative colitis	6.52e-06	5.05e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—PTGS1—ulcerative colitis	6.41e-06	4.97e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—MMP9—ulcerative colitis	6.2e-06	4.81e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—NFKB1—ulcerative colitis	6.13e-06	4.75e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—TP53—ulcerative colitis	6.08e-06	4.71e-05	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—IL6—ulcerative colitis	5.95e-06	4.62e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—PPARG—ulcerative colitis	5.81e-06	4.51e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—CALM3—ulcerative colitis	5.77e-06	4.47e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—IL6—ulcerative colitis	5.56e-06	4.31e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—STAT3—ulcerative colitis	5.51e-06	4.27e-05	CbGpPWpGaD
Dabrafenib—RAF1—Disease—IL6—ulcerative colitis	5.5e-06	4.26e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—ALB—ulcerative colitis	5.23e-06	4.05e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—TGFB1—ulcerative colitis	5.11e-06	3.96e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—PPARG—ulcerative colitis	5.07e-06	3.93e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—PTGS2—ulcerative colitis	4.57e-06	3.55e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—ALB—ulcerative colitis	4.55e-06	3.53e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—ABCB1—ulcerative colitis	4.49e-06	3.48e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—TP53—ulcerative colitis	4.21e-06	3.26e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—ADCY5—ulcerative colitis	4.18e-06	3.24e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—PTGS2—ulcerative colitis	3.98e-06	3.09e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—IL6—ulcerative colitis	3.85e-06	2.98e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—PPARG—ulcerative colitis	3.12e-06	2.42e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—ALB—ulcerative colitis	2.81e-06	2.18e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—PTGS2—ulcerative colitis	2.45e-06	1.9e-05	CbGpPWpGaD
